Clinical Potential for Use of LSD and MDMA in Treatment of Trauma Healing Highs: the Clinical Potential for the Use of Lysergic Acid Diethylmide (lsd-25) and 3,4-Methylenedioxy-methamphetamine (MDMA) in the Treatment of Psychological Trauma
MetadataShow full item record
Trauma, including Post Traumatic Stress Disorder, is a prevalent and challenging issue in the psychology field, with a number of treatment approaches with varying degrees of success. Historically, the psychedelic substances lysergic acid diethylamide (LSD-25) and 3,4-methylenedioxy-methamphetamine (MDMA) were used in therapeutic settings, under the supervision of trained practitioners. However, prohibition and the subsequent scheduling of these substances as illicit effectively halted their use in therapy and ceased exploration of their therapeutic potential. As a result, a generation of therapists has been uninformed of the potential of these psychedelic substances as an adjunct to psychological therapy, including in the treatment of trauma. This qualitative thesis will aim to uncover the history behind these substances, their relationship to psychotherapy, and the more recent utilization of them in our culture of psychotherapy through a best practices document analysis and synthesis. Exploring the use of psychedelics in treating trauma will provide further insight into the ways in which we approach and deal with psychological healing.